These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5612203)

  • 1. [The fibrinolytic system of the blood in hypertension and its changes under the effect of complex therapy].
    Atamanchuk NS
    Vrach Delo; 1967 Apr; 4():73-6. PubMed ID: 5612203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic system in patients with acute hypertension without renal failure].
    Lasierra Cirujeda J; Ramos González I
    Rev Clin Esp; 1980 Jan; 156(2):93-7. PubMed ID: 7367705
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of losartan and Nitrendipine on fibrinolytic system in patient with essential hypertensim].
    Yin P; Wang L; Rong YD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):556. PubMed ID: 12971855
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of euphylline on the fibrinolytic system of blood in patients with atherosclerosis and hypertensive disease].
    Bogomolova EK; Sukhanov AA; Iastrebova LP; Iampol'skaia LA
    Klin Med (Mosk); 1975 Apr; 53(4):51-3. PubMed ID: 1152372
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cilazapril on fibrinolytic system in hypertensive patients.
    Hosgor I; Ahmad S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):101-5. PubMed ID: 18180626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of refractory hypertension by combination of direct vasodilators.
    Gerlag PG
    Neth J Med; 1983; 26(9):271-3. PubMed ID: 6656978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hypotensive preparations on the blood coagulation and fibrinolysis indices in hypertension].
    Tsyrul'neva NI
    Vrach Delo; 1980 Oct; (10):32-5. PubMed ID: 7434699
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Maintenance" therapy of patients with hypertension and coronary atherosclerosis].
    Brovko-Burkhanova NZ; Tondiĭ LD; Shabel'nik VI
    Vrach Delo; 1969 Nov; 11():23-7. PubMed ID: 5384414
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters.
    Zehetgruber M; Christ G; Gabriel H; Mundigler G; Beckmann R; Binder BR; Huber K
    Thromb Haemost; 1998 Feb; 79(2):378-82. PubMed ID: 9493594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan, an angiotensin II receptor antagonist, on the fibrinolytic system in hypertensive patients.
    Saito M; Kawasaki S; Hashiba T; Chen CJ; Hatakeyama H; Asakura H; Kikuchi M; Matsuda T
    Int J Hematol; 1999 Jul; 70(1):60-1. PubMed ID: 10446499
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 14. [The possibilities of arifon in the combined therapy of unstable stenocardia in persons with arterial hypertension].
    Iakovlev VM; Sokolov GS
    Ter Arkh; 1997; 69(6):53-5. PubMed ID: 9297277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of sclerotic hypertension].
    Petruk AE; Andrenko PT
    Vrach Delo; 1967 Aug; 8():31-4. PubMed ID: 5612695
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of hypertension: 1980.
    Hall WD
    J Med Assoc Ga; 1980 Sep; 69(9):745-8. PubMed ID: 6106659
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis.
    Erlinger TP; Conlin PR; Macko RF; Bohannon AD; Miller ER; Moore TJ; Svetkey LP; Appel LJ
    J Hum Hypertens; 2002 Jun; 16(6):391-7. PubMed ID: 12037693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the vasodilator minoxidil in resistant hypertension.
    Black RN; Hunter SJ; Atkinson AB
    J Hypertens; 2007 May; 25(5):1102-3; author reply 1103. PubMed ID: 17414678
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerance of the new long-acting vasodilator RO 12-4713 in hypertensive patients not managed on beta blockers and diuretics.
    Amann FW; Bolli P; Bühler FR
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):13-5. PubMed ID: 6142004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.